Evaluating Precision Medicine in Advanced Prostate Cancer

Dr. Rupert Ecker co-authored a review on genomic and phenotypic biomarkers guiding precision medicine in advanced prostate cancer, highlighting strategies for diagnosis, prognosis, and treatment prediction.

oncology

biomarker discovery

precision medicine

expert insights

Customer Publication

Dynamic Content Image

Evaluating Precision Medicine in Advanced Prostate Cancer

10 Aug, 2023

https://doi.org/10.1007/s11864-023-01121-z

LogoOrangewhite2025

TissueGnostics GmbH
Taborstraße 10/2/8
1020 Vienna, Austria
+43 1 216 11 90
This email address is being protected from spambots. You need JavaScript enabled to view it.

Contact us

About Us

TissueGnostics provides advanced solutions for whole-slide imaging and image analysis in biological and clinical research. Our products help researchers to scan and analyze complex tissue samples, enabling more detailed insights into tissue structure, cellular interactions, and spatial cell landscape.

Keep in Touch

Be the first to hear about the latest scientific updates.